It is important to identify risk factors for poor outcomes of coronavirus disease 2019 (COVID-
19) patients. Currently, the correlation between non-alcoholic fatty liver disease (NAFLD) …

In late 2019, the world was shaken by the COVID-19 pandemic. Severe Acute Respiratory
Syndrome Coronavirus—2 (SARS-CoV-2) infection became one of the main causes of …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease showing a rising prevalence globally. Genetic predisposition plays a key role in the …

The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2, has become a global challenge of unprecedented …

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty
liver disease (MAFLD) are on the rise like any other liver disease, and tend to affect 25% of …

Healthcare visits were reduced during the COVID-19 pandemic, causing disturbances in
sustainable MAFLD monitoring. Telemedicine acts to maintain connectivity between patients …

Background: Steatotic liver disease (SLD) has been linked to more exacerbated
inflammatory responses in various scenarios. The relationship between SLD and COVID-19 …

Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory …

Abstract The coronavirus 2019 disease (COVID-19) is caused by a novel coronavirus,
severe acute respiratory syndrome coronavirus 2. This disease was designated by the World …

Вступ. Впродовж останніх трьох років світова спільнота бореться із гострим перебігом
та із залишковими проявами коронавірусної інфекції COVID-19, що продовжує …